Search

everythinglearnresearchcommunity

for

Search:↓

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

Antera 3D® offers more precise and detailed scar assessment than traditional methods.

Trichoscan® is best for measuring hair growth, RCM for analyzing hair follicles, and OCT is useful for both.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

The study created a 27-item measure to assess the impact of skin diseases.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Trichoepitheliomas can be hard to distinguish from other skin conditions and often start in teenage years.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

New standards were created to make chemotherapy safer and improve cancer care.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The prototype for analyzing skin aging works technically and clinically.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Standardized data is essential for diagnosing scalp and hair conditions in males.

Erlotinib can cause persistent excessive hair growth.

CAL-PDT is safer and more effective for treating actinic keratosis on the scalp.

The Trichoscope is a valuable tool for diagnosing and monitoring hair loss conditions.

The TrichoScan method effectively measures hair growth and helps choose patients for hair restoration surgery.

The new SFS Scale predicts hair transplant difficulty using hair and skin types, with thick skin and coily hair being hardest to work with.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Reducing gefitinib dosage improved hair loss, but scarring remained.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

TrichoScan accurately measures hair growth and loss, showing increased hair counts and thickness with treatment.